Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years

Harris, John E.Pandya, Amit G.Lebwohl, MarkHamzavi, Iltefat H.Grimes, PearlGottlieb, Alice B.Sofen, Howard L.Moore, Angela Y.Wang, MingyueKornacki, DeannaButler, KathleenRosmarin, David2025-01-272025-01-272024-08-07Harris JE, Pandya AG, Lebwohl M, et al. Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years. Skin Health Dis. 2024;4(6):e404. Published 2024 Aug 7. doi:10.1002/ski2.404https://hdl.handle.net/1805/45482en-USAttribution 4.0 InternationalVitiligoSkin depigmentationRuxolitinib creamSafety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 yearsArticle